IQAir® Cleanroom H13

IQAir systems feature patented triple sealing technology. First, a unique process ensures that the filter media is 100% sealed in the filter frame. Second, our patented 3D UltraSeal ensures perfect sealing between filter frame and housing. Third, individual seals on each housing module ensure an air tight housing. As a result, IQAir® systems have an actual system efficiency which is higher than the theoretical efficiency of conventional air cleaners.

The IQAir® Cleanroom Series has been designed specifically for the removal of airborne particles. The systems feature the highest air delivery and longest filter life of any IQAir particle filter system. To allow for maximum air delivery the systems contain no gas phase filtration.

The Cleanroom Series provides a choice of 2 models, each with a specific filter efficiency and air delivery profile. While healthcare facilities may require higher air delivery to achieve optimum control of microorganisms (e.g. in ICUs or TB isolation rooms), a cleanroom facility may need a filtration efficiency of 99.97% to meet strict manufacturing regulations or standards.

Each IQAir® Cleanroom system can be used as a recirculation device or it can be combined with IQAir's ducting adapters InFlow W125 or OutFlow W125 to create positive and negative pressure environments. The creation of negative pressure helps to contain harmful particles, such as microorganisms, in a particular area (e.g. TB isolation).

The creation of positive pressure helps to protect clean areas from contaminants entering from adjacent rooms (e.g. protective isolation of immuno-compromised patients, controlled environments for medical device manufacturing).

Airborne pathogens in health-care environments pose a particular risk to immunocompromised patients who may inhale fungal spores, bacteria and viruses. Airborne microorganisms can not only complicate recovery from surgery, but can also lead to life-threatening infections,costing health-care services hundreds of millions every year.

Hospital-acquired aspergillosis for example has been recognised increasingly as a cause of severe illness and high mortality in immunocompromised individuals, e.g. patients undergoing chemotherapy and/or organ or bone marrow transplants. In the light of the marked increase in nosocomial infections over recent years, many of which are caused by drug-resistant pathogens, the importance of using high-efficiency air filtration systems beyond the confines of so-called ¡°critical areas¡± (such as operation theatres) has once again been emphasised. Both the World Health Organisation (WHO) and the Centers for Disease Control and Prevention (CDC), advise that, wherever possible, preventive infection control measures should be implemented to reduce the risk of nosocomial infections.

For more critical control of gaseous compounds see GC Series models.

99.99% or more at 0.3 microns
99.7% for smaller particles